Funding Rounds
Amolyt Pharma

Amolyt Pharma Series C (2023, $138M)

Amolyt Pharma

Peptides for the treatment of rare endocrine and related diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $138.63M

Raised Date: 2023-06-01

Investors